Cargando…
Translational proteomics in cardiogenic shock: from benchmark to bedside
Autores principales: | Iborra-Egea, Oriol, Bayes-Genis, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915419/ https://www.ncbi.nlm.nih.gov/pubmed/35317390 http://dx.doi.org/10.11909/j.issn.1671-5411.2022.02.007 |
Ejemplares similares
-
Commentary: A Review of Prognosis Model Associated With Cardiogenic Shock After Acute Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
Different Effects on Protein Expression of CDR132L, an Antisense Inhibitor of miR-132, and Standard Therapies for Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
Statins for Patients with Cardiogenic Shock
por: Champion, Sébastien
Publicado: (2014) -
Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017) -
Apical Ballooning and Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2018)